Position in BMRN
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$1,115,503
+$346,279 QoQ
Shares Held
19,495
+43.2% QoQ
Ownership
0.010%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#266
of 561 holders
Holding Since
Mar 2020
24 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in BMRN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026NATIXIS ADVISORS, LLC holds $495,549,179 across 38 Biotechnology names. BMRN ranks #27 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
448,631 | $222,848,476 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
129,236 | $80,583,815 | |
| 3 | TECH |
BIO-TECHNE Corp
|
818,905 | $57,855,638 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
75,311 | $22,670,870 | |
| 5 | ARGX |
Argenx SE
|
19,088 | $17,709,273 | |
| 6 | INSM |
INSMED Inc
|
73,607 | $7,847,978 | |
| 7 | HALO |
Halozyme Therapeutics, Inc.
|
97,536 | $7,634,142 | |
| 8 | JAZZ |
Jazz Pharmaceuticals plc
|
29,928 | $7,211,749 |
All Filings in BMRN
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,115,503 | 19,495 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $769,224 | 13,617 | Shares | Defined | 2026-05-13 | |
| 2025-09-30 | $596,734 | 11,018 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $1,386,893 | 25,230 | Shares | Defined | 2025-08-13 | |
| 2025-03-31 | $2,348,745 | 33,226 | Shares | Defined | 2025-05-08 | |
| 2024-12-31 | $1,297,378 | 19,738 | Shares | Defined | 2025-02-10 | |
| 2024-06-30 | $1,556,119 | 18,901 | Shares | Defined | 2024-08-01 | |
| 2024-03-31 | $4,842,915 | 55,449 | Shares | Defined | 2024-04-25 | |
| 2023-12-31 | $5,748,463 | 59,619 | Shares | Defined | 2024-02-06 | |
| 2023-09-30 | $5,297,032 | 59,867 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $5,179,216 | 59,751 | Shares | Defined | 2023-08-15 | |
| 2023-03-31 | $5,927,555 | 60,958 | Shares | Defined | 2023-05-11 | |
| 2022-12-31 | $6,452,084 | 62,345 | Shares | Defined | 2023-01-27 | |
| 2022-09-30 | $6,407,255 | 75,584 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $5,669,385 | 68,413 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $4,654,218 | 60,366 | Shares | Defined | 2022-05-12 | |
| 2021-12-31 | $5,688,149 | 64,382 | Shares | Defined | 2022-02-08 | |
| 2021-09-30 | $4,290,754 | 55,515 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $2,519,971 | 30,201 | Shares | Defined | 2021-08-12 | |
| 2021-03-31 | $1,515,032 | 20,064 | Shares | Defined | 2021-05-05 | |
| 2020-12-31 | $4,791,907 | 54,646 | Shares | Defined | 2021-02-12 | |
| 2020-09-30 | $2,866,542 | 37,678 | Shares | Defined | 2020-11-12 | |
| 2020-06-30 | $4,134,973 | 33,525 | Shares | Defined | 2020-08-11 | |
| 2020-03-31 | $1,307,384 | 15,472 | Shares | Defined | 2020-04-27 | |
| No filing history on record for this holder in this stock. | ||||||